Pierce Glenn
- SEC CIK
- 0001256964
No open-market purchases or sales filed in the past year.
Current role at each company
- VYGR Voyager Therapeutics, Inc.Directoras of Jun 11, 2026
- GBT Global Blood Therapeutics, Inc.Directoras of Oct 6, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pierce Glenn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VYGR Voyager Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2022 (view filing) | Jul 14 | 4 days | Pierce GlennDirector | SSale | −9.51K | $6.70 | −$63.7K | −36.2%16.8K after |